Lucid Diagnostics Inc. Sale of Stock, Consideration Received on Transaction
Lucid Diagnostics Inc. (LUCD) reported Sale of Stock, Consideration Received on Transaction of $50.00 million for the 0-month period ending 2022-03-28, per its 10-Q filed 2022-08-15.
Discontinued › Notes
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2022-08-15
- 2022-03-28: Sale of Stock, Consideration Received on Transaction 0 month $50.00M.
| Period end | Sale of Stock, Consideration Received on Transaction 0 month |
|---|---|
| 2022-03-28 | $50.00M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |